ZA745513B - Therapeutic composition containing a higher alkanol - Google Patents

Therapeutic composition containing a higher alkanol

Info

Publication number
ZA745513B
ZA745513B ZA00745513A ZA745513A ZA745513B ZA 745513 B ZA745513 B ZA 745513B ZA 00745513 A ZA00745513 A ZA 00745513A ZA 745513 A ZA745513 A ZA 745513A ZA 745513 B ZA745513 B ZA 745513B
Authority
ZA
South Africa
Prior art keywords
composition containing
therapeutic composition
higher alkanol
alkanol
therapeutic
Prior art date
Application number
ZA00745513A
Other languages
English (en)
Inventor
J Debat
Original Assignee
Irceba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irceba filed Critical Irceba
Publication of ZA745513B publication Critical patent/ZA745513B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA00745513A 1973-08-29 1974-08-28 Therapeutic composition containing a higher alkanol ZA745513B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4056873A GB1459233A (en) 1973-08-29 1973-08-29 Medicament containing a higher alkanol

Publications (1)

Publication Number Publication Date
ZA745513B true ZA745513B (en) 1975-08-27

Family

ID=10415549

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00745513A ZA745513B (en) 1973-08-29 1974-08-28 Therapeutic composition containing a higher alkanol

Country Status (18)

Country Link
US (1) US4186211A (de)
JP (1) JPS5076220A (de)
AR (1) AR205721A1 (de)
BE (1) BE819296A (de)
CA (1) CA1036940A (de)
CH (1) CH593218A5 (de)
DE (1) DE2440436C3 (de)
DK (1) DK456674A (de)
ES (1) ES429585A1 (de)
FI (1) FI251974A (de)
FR (1) FR2242080B1 (de)
GB (1) GB1459233A (de)
IE (1) IE39671B1 (de)
IL (1) IL45538A (de)
NL (1) NL7411312A (de)
NO (1) NO743077L (de)
SE (1) SE7410889L (de)
ZA (1) ZA745513B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340628A (en) 1979-01-25 1982-07-20 Gilbertson John R Antibacterial agent and method
US4209533A (en) 1979-01-25 1980-06-24 University Of Pittsburgh Antibacterial agent and method
US4372978A (en) 1979-11-26 1983-02-08 University Of Pittsburgh Antibacterial agent and method
DE3348493C2 (de) * 1982-05-28 1998-09-17 Eisai Co Ltd Verwendung von Docosanol zur Behandlung und Prophylaxe von durch Immunmangelerscheinungen verursachten Infektionskrankheiten
DE3348500C2 (de) * 1982-05-28 1998-10-22 Eisai Co Ltd beta,gamma-Dihydropolyprenylalkoholderivat
FR2532845B1 (fr) * 1982-05-28 1988-01-15 Eisai Co Ltd Composition pharmaceutique comprenant a titre de principe actif le docosanol
IT1213176B (it) * 1984-06-11 1989-12-14 Milano A Composizioni e composti per il trattamento dell'adenoma prostatico.
US5070107A (en) * 1989-04-28 1991-12-03 Lidak Pharmaceuticals Systemic antiviral treatment
US5071879A (en) * 1989-04-28 1991-12-10 Lidak Pharmaceuticals Systemic antiviral treatment
US5166219A (en) * 1989-11-02 1992-11-24 Lidak Pharmaceuticals Systemic anti-inflammatory treatment
DK0738141T3 (da) * 1993-12-13 2008-05-19 Avanir Pharmaceuticals Sucroseester- og n-docosanolformuleringer
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US5948822A (en) 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
PT102410A (pt) * 2000-02-03 2001-08-30 Qualitas Lab Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ n−ドコサノールによるウイルス阻害
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031376A (en) * 1956-10-11 1962-04-24 Levin Compositions comprising octacosanol, triacontanol, tetracosanol, or hexacosanol, andmethods employing same
US3226295A (en) * 1960-02-08 1965-12-28 Carlos C Goetz Method of making cetyl alcohol emulsions
US3646215A (en) * 1969-11-26 1972-02-29 Commodity Improvements Inc Heptadecanol for medical purposes
US3929869A (en) * 1972-06-29 1975-12-30 Labaz Pentanol derivatives

Also Published As

Publication number Publication date
FR2242080B1 (de) 1978-07-21
SE7410889L (de) 1975-03-03
DE2440436C3 (de) 1982-03-18
US4186211A (en) 1980-01-29
CH593218A5 (de) 1977-11-30
IE39671L (en) 1975-02-28
DK456674A (de) 1975-04-28
DE2440436B2 (de) 1981-02-26
GB1459233A (en) 1976-12-22
DE2440436A1 (de) 1975-03-06
CA1036940A (en) 1978-08-22
NL7411312A (nl) 1975-03-04
NO743077L (de) 1975-03-24
AR205721A1 (es) 1976-05-31
AU7277374A (en) 1976-03-04
FR2242080A1 (de) 1975-03-28
FI251974A (de) 1975-03-01
JPS5076220A (de) 1975-06-21
IE39671B1 (en) 1978-12-06
ES429585A1 (es) 1976-09-16
IL45538A (en) 1978-06-15
BE819296A (fr) 1974-12-16
IL45538A0 (en) 1974-11-29

Similar Documents

Publication Publication Date Title
AU6389073A (en) A game
AU7259274A (en) Medicaments
ZA743934B (en) Pharmaceutical compositions
ZA745513B (en) Therapeutic composition containing a higher alkanol
ZA732683B (en) Therapeutic agent
ZA744616B (en) Therapeutic supplementary feed composition
HK72578A (en) Pharmaceutical compositions
AU7201374A (en) Pharmaceutical compositions
ZA744488B (en) Pharmaceutical compositions
ZA745756B (en) Pharmaceutical compositions
ZA743124B (en) Therapeutic agents
YU180274A (en) Dentistry patient-chair
ZA747402B (en) Photopolymerisable composition
ZA742064B (en) Pharmaceutical compositions
AU7349374A (en) Medicinal composition
ZA745114B (en) A medicament- thiazole 5-methanol and pharmaceutical compositions containing
AU7567574A (en) Nozzle
BG28272A3 (en) Nozzle unit
IL44413A0 (en) Pharmaceutical compositions containing a furanofuran derivative
IL44357A0 (en) Composition containing a pyrazinoiso-quinoline derivative
AU6798474A (en) Dispenser
AU6774874A (en) Dispenser
AU6543474A (en) Medicament pack
AU7609274A (en) Photopolymerisable composition
ZA741050B (en) Pharmaceutical compositions